{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:44:45Z","timestamp":1789757085380,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["KFOC160013"],"award-info":[{"award-number":["KFOC160013"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec-Sant\u00e9","doi-asserted-by":"publisher","award":["32661"],"award-info":[{"award-number":["32661"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00774-018-0919-y","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T09:40:50Z","timestamp":1522402850000},"page":"212-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats"],"prefix":"10.1007","volume":"37","author":[{"given":"Sarah-Kim","family":"Bisson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roth-Visal","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danika","family":"Valade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Agharazii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Larivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-9344","authenticated-orcid":false,"given":"Fabrice","family":"Mac-Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"919_CR1","doi-asserted-by":"publisher","unstructured":"(2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl S1\u2013S130 https:\/\/doi.org\/10.1038\/ki.2009.188","DOI":"10.1038\/ki.2009.188"},{"key":"919_CR2","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/ndt\/gft514","volume":"29","author":"M Cozzolino","year":"2014","unstructured":"Cozzolino M, Urena-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S, ERA-EDTA C-MWGo (2014) Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? Nephrol Dial Transplant 29:1815\u20131820. https:\/\/doi.org\/10.1093\/ndt\/gft514","journal-title":"Nephrol Dial Transplant"},{"key":"919_CR3","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","volume":"100","author":"CM Shanahan","year":"1999","unstructured":"Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg\u2019s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168\u20132176","journal-title":"Circulation"},{"key":"919_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","volume":"43","author":"WG Goodman","year":"2004","unstructured":"Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N, Vascular Calcification Work G (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572\u2013579","journal-title":"Am J Kidney Dis"},{"key":"919_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.semnephrol.2003.08.013","volume":"24","author":"C Stehman-Breen","year":"2004","unstructured":"Stehman-Breen C (2004) Osteoporosis and chronic kidney disease. Semin Nephrol 24:78\u201381","journal-title":"Semin Nephrol"},{"key":"919_CR6","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1681\/ASN.2009121208","volume":"21","author":"TL Nickolas","year":"2010","unstructured":"Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, Leonard MB, Shane E (2010) Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 21:1371\u20131380. https:\/\/doi.org\/10.1681\/ASN.2009121208","journal-title":"J Am Soc Nephrol"},{"key":"919_CR7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1681\/ASN.V92267","volume":"9","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16\u2013S23","journal-title":"J Am Soc Nephrol"},{"key":"919_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5414\/CN107515","volume":"78","author":"R Watanabe","year":"2012","unstructured":"Watanabe R, Lemos MM, Carvalho AB, Rochitte CE, Santos RD, Draibe SA, Canziani ME (2012) The association between coronary artery calcification progression and loss of bone density in non-dialyzed CKD patients. Clin Nephrol 78:425\u2013431. https:\/\/doi.org\/10.5414\/CN107515","journal-title":"Clin Nephrol"},{"key":"919_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/ndt\/gfm660","volume":"23","author":"ND Toussaint","year":"2008","unstructured":"Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23:586\u2013593. https:\/\/doi.org\/10.1093\/ndt\/gfm660","journal-title":"Nephrol Dial Transplant"},{"key":"919_CR10","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1161\/01.ATV.20.8.1926","volume":"20","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC (2000) Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 20:1926\u20131931","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"919_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Drueke","year":"2016","unstructured":"Drueke TB, Massy ZA (2016) Changing bone patterns with progression of chronic kidney disease. Kidney Int 89:289\u2013302. https:\/\/doi.org\/10.1016\/j.kint.2015.12.004","journal-title":"Kidney Int"},{"key":"919_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ki.2008.60","volume":"73","author":"DL Andress","year":"2008","unstructured":"Andress DL (2008) Adynamic bone in patients with chronic kidney disease. Kidney Int 73:1345\u20131354. https:\/\/doi.org\/10.1038\/ki.2008.60","journal-title":"Kidney Int"},{"key":"919_CR13","first-page":"S62","volume":"38","author":"HH Malluche","year":"1992","unstructured":"Malluche HH, Monier-Faugere MC (1992) Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 38:S62\u2013S67","journal-title":"Kidney Int Suppl"},{"key":"919_CR14","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"GM London","year":"2004","unstructured":"London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943\u20131951","journal-title":"J Am Soc Nephrol"},{"key":"919_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MNH.0b013e32832c4df0","volume":"18","author":"JM Frazao","year":"2009","unstructured":"Frazao JM, Martins P (2009) Adynamic bone disease: clinical and therapeutic implications. Curr Opin Nephrol Hypertens 18:303\u2013307. https:\/\/doi.org\/10.1097\/MNH.0b013e32832c4df0","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"919_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8:819\u2013823. https:\/\/doi.org\/10.2215\/CJN.07670712","journal-title":"Clin J Am Soc Nephrol"},{"key":"919_CR17","doi-asserted-by":"publisher","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","volume":"8","author":"JC Ferreira","year":"2013","unstructured":"Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, Dos Reis LM, Graciolli FG, Oliveira EC, Liu S, Sabbagh Y, Jorgetti V, Schiavi S, Moyses RM (2013) Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease\u2014role of sclerostin? PLoS One 8:e79721. https:\/\/doi.org\/10.1371\/journal.pone.0079721PONE-D-13-17719","journal-title":"PLoS One"},{"key":"919_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.372","volume":"87","author":"RA Oliveira de","year":"2015","unstructured":"de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moyses RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039\u20131045. https:\/\/doi.org\/10.1038\/ki.2014.372","journal-title":"Kidney Int"},{"key":"919_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","volume":"34","author":"J Bover","year":"2014","unstructured":"Bover J, Urena P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, Bosch RJ (2014) Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol 34:626\u2013640. https:\/\/doi.org\/10.1016\/j.semnephrol.2014.09.008","journal-title":"Semin Nephrol"},{"key":"919_CR20","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2013.804541","author":"A Gauthier-Bastien","year":"2013","unstructured":"Gauthier-Bastien A, Ung RV, Lariviere R, Mac-Way F, Lebel M, Agharazii M (2013) Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens. https:\/\/doi.org\/10.3109\/10641963.2013.804541","journal-title":"Clin Exp Hypertens"},{"key":"919_CR21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ajh\/hpu225","volume":"28","author":"M Agharazii","year":"2015","unstructured":"Agharazii M, St-Louis R, Gautier-Bastien A, Ung RV, Mokas S, Lariviere R, Richard DE (2015) Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens 28:746\u2013755. https:\/\/doi.org\/10.1093\/ajh\/hpu225","journal-title":"Am J Hypertens"},{"key":"919_CR22","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45","journal-title":"Nucleic Acids Res"},{"key":"919_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0065-1281(87)80012-0","volume":"81","author":"D Chappard","year":"1987","unstructured":"Chappard D, Palle S, Alexandre C, Vico L, Riffat G (1987) Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities. Acta Histochem 81:183\u2013190. https:\/\/doi.org\/10.1016\/S0065-1281(87)80012-0","journal-title":"Acta Histochem"},{"key":"919_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610. https:\/\/doi.org\/10.1002\/jbmr.5650020617","journal-title":"J Bone Miner Res"},{"key":"919_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2\u201317. https:\/\/doi.org\/10.1002\/jbmr.1805","journal-title":"J Bone Miner Res"},{"key":"919_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","volume":"36","author":"SM Moe","year":"2006","unstructured":"Moe SM (2006) Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Investig 36:51\u201362. https:\/\/doi.org\/10.1111\/j.1365-2362.2006.01665.x","journal-title":"Eur J Clin Investig"},{"key":"919_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","volume":"2","author":"MG Vervloet","year":"2014","unstructured":"Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Urena-Torres P, Bover J, Goldsmith D, ERA-EDTA C-MWGo (2014) Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol 2:427\u2013436. https:\/\/doi.org\/10.1016\/S2213-8587(14)70059-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"919_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3069-7","author":"VM Brandenburg","year":"2015","unstructured":"Brandenburg VM, D\u2019Haese P, Deck A, Mekahli D, Meijers B, Neven E, Evenepoel P (2015) From skeletal to cardiovascular disease in 12 steps\u2014the evolution of sclerostin as a major player in CKD-MBD. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-015-3069-7","journal-title":"Pediatr Nephrol"},{"key":"919_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bone.2013.02.022","volume":"54","author":"TA Burgers","year":"2013","unstructured":"Burgers TA, Williams BO (2013) Regulation of Wnt\/beta-catenin signaling within and from osteocytes. Bone 54:244\u2013249. https:\/\/doi.org\/10.1016\/j.bone.2013.02.022","journal-title":"Bone"},{"key":"919_CR30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.yexcr.2016.06.007","volume":"345","author":"T Cai","year":"2016","unstructured":"Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J, He W (2016) WNT\/beta-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res 345:206\u2013217. https:\/\/doi.org\/10.1016\/j.yexcr.2016.06.007","journal-title":"Exp Cell Res"},{"key":"919_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1371\/journal.pone.0079721","volume":"8","author":"JC Ferreira","year":"2013","unstructured":"Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, dos Reis LM, Graciolli FG, Oliveira EC, Liu SG, Sabbagh Y, Jorgetti V, Schiavi S, Moyses RMA (2013) Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease\u2014role of sclerostin? PLoS One 8:7. https:\/\/doi.org\/10.1371\/journal.pone.0079721","journal-title":"PLoS One"},{"key":"919_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-Lopez","year":"2016","unstructured":"Carrillo-Lopez N, Panizo S, Alonso-Montes C, Roman-Garcia P, Rodriguez I, Martinez-Salgado C, Dusso AS, Naves M, Cannata-Andia JB (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90:77\u201389. https:\/\/doi.org\/10.1016\/j.kint.2016.01.024","journal-title":"Kidney Int"},{"key":"919_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1371\/journal.pone.0020772","volume":"6","author":"A Idelevich","year":"2011","unstructured":"Idelevich A, Kerschnitzki M, Shahar R, Monsonego-Ornan E (2011) 1,25(OH)(2)D-3 alters growth plate maturation and bone architecture in young rats with normal renal function. PLoS One 6:14. https:\/\/doi.org\/10.1371\/journal.pone.0020772","journal-title":"PLoS One"},{"key":"919_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/01.rct.0000238007.19258.3d","volume":"31","author":"TAJ Hopper","year":"2007","unstructured":"Hopper TAJ, Wehrli FW, Saha PK, Andre JB, Wright AC, Sanchez CP, Leonard MB (2007) Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy. J Comput Assist Tomogr 31:320\u2013328. https:\/\/doi.org\/10.1097\/01.rct.0000238007.19258.3d","journal-title":"J Comput Assist Tomogr"},{"key":"919_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ki.1997.297","volume":"52","author":"AM Parfitt","year":"1997","unstructured":"Parfitt AM (1997) The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 52:3\u20139. https:\/\/doi.org\/10.1038\/ki.1997.297","journal-title":"Kidney Int"},{"key":"919_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bone.2007.06.026","volume":"41","author":"MN Diaz","year":"2007","unstructured":"Diaz MN, Rodriguez AR, Martin JLF, Arias MS, Rodriguez PM, Cannata Andia JB (2007) Effects of estradiol, calcitriol and both treatments combined on bone histomorphometry in rats with chronic kidney disease and ovariectomy. Bone 41:614\u2013619. https:\/\/doi.org\/10.1016\/j.bone.2007.06.026","journal-title":"Bone"},{"key":"919_CR37","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1210\/endo-119-6-2580","volume":"119","author":"TJ Wronski","year":"1986","unstructured":"Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER (1986) Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinology 119:2580\u20132585. https:\/\/doi.org\/10.1210\/endo-119-6-2580","journal-title":"Endocrinology"},{"key":"919_CR38","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1172\/JCI45890","volume":"122","author":"L Lieben","year":"2012","unstructured":"Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, Lafage-Proust MH, Dresselaers T, Feng JQ, Bonewald LF, Meyer MB, Pike JW, Bouillon R, Carmeliet G (2012) Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Investig 122:1803\u20131815. https:\/\/doi.org\/10.1172\/JCI45890","journal-title":"J Clin Investig"},{"key":"919_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00223-012-9635-0","volume":"91","author":"TM Schutter De","year":"2012","unstructured":"De Schutter TM, Behets GJ, Jung S, Neven E, D\u2019Haese PC, Querfeld U (2012) Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats. Calcif Tissue Int 91:307\u2013315. https:\/\/doi.org\/10.1007\/s00223-012-9635-0","journal-title":"Calcif Tissue Int"},{"key":"919_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semnephrol.2012.12.017","volume":"33","author":"K Wesseling-Perry","year":"2013","unstructured":"Wesseling-Perry K, Salusky IB (2013) Chronic kidney disease: mineral and bone disorder in children. Semin Nephrol 33:169\u2013179. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.017","journal-title":"Semin Nephrol"},{"key":"919_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000444423","volume":"43","author":"CL Newman","year":"2016","unstructured":"Newman CL, Tian N, Hammond MA, Wallace JM, Brown DM, Chen NX, Moe SM, Allen MR (2016) Calcitriol suppression of parathyroid hormone fails to improve skeletal properties in an animal model of chronic kidney disease. Am J Nephrol 43:20\u201331. https:\/\/doi.org\/10.1159\/000444423","journal-title":"Am J Nephrol"},{"key":"919_CR42","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ajh\/hpu057","volume":"27","author":"C Fortier","year":"2014","unstructured":"Fortier C, Mac-Way F, De Serres SA, Marquis K, Douville P, Desmeules S, Lariviere R, Agharazii M (2014) Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study. Am J Hypertens 27:1346\u20131354. https:\/\/doi.org\/10.1093\/ajh\/hpu057","journal-title":"Am J Hypertens"},{"key":"919_CR43","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/jbmr.345","volume":"26","author":"GJ Atkins","year":"2011","unstructured":"Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR, Zelenchuk L, Evdokiou A, Findlay DM (2011) Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26:1425\u20131436. https:\/\/doi.org\/10.1002\/jbmr.345","journal-title":"J Bone Miner Res"},{"key":"919_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","volume":"89","author":"V Shalhoub","year":"2011","unstructured":"Shalhoub V, Ward SC, Sun B, Stevens J, Renshaw L, Hawkins N, Richards WG (2011) Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int 89:140\u2013150. https:\/\/doi.org\/10.1007\/s00223-011-9501-5","journal-title":"Calcif Tissue Int"},{"key":"919_CR45","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1097\/HJH.0b013e328357c049","volume":"30","author":"S Jung","year":"2012","unstructured":"Jung S, Querfeld U, Muller D, Rudolph B, Peters H, Kramer S (2012) Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats. J Hypertens 30:2182\u20132191. https:\/\/doi.org\/10.1097\/HJH.0b013e328357c049","journal-title":"J Hypertens"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0919-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-018-0919-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0919-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T13:56:05Z","timestamp":1660744565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-018-0919-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s00774-018-0919-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,30]]},"assertion":[{"value":"5 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}